Germacrene D
Based on 1 publication(s) in Google Scholar
Germacrene D is isolated from Solidago canadensis. Germacrene D has antibacterial and antifungal activities and can be used as an adjuvant agent in the application of aminoglycosides and azoles.
For research use only. We do not sell to patients.
- Purity : 93.34%
- CAS No.: 23986-74-5
- Formula: C15H24
- Molecular Weight:204.35
-
Storage:
Solution, -20°C, protect from light, 2 years
Publications Citing Use of MedChemExpress (MCE) Germacrene D
More
Biological Activity
Description
IC50 & Target
IC50: bacterial[1]
In Vitro
Germacrene D shows antibacterial and antifungal activities, the mechanism of antimicrobial action of it may be related to permeabilization of the cells and disruption of the membrane integrity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 23986-74-5
-
Appearance Liquid
-
Molecular Weight 204.35
-
Formula C15H24
-
Color Colorless to light yellow
-
SMILES
CC([C@H]1/C=C/C(CC/C=C(C)/CC1)=C)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Solution, -20°C, protect from light, 2 years
Publications (1)
-
Journal Impact Factor
-
Most Recent
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)